Medlab Clinical Ltd. announced, pursuant to the Pharmacare Australian nutraceutical deal announced in November 2021, Medlab has invoiced $275K (incl. GST) to PharmaCare for the first royalty cheque. Proceeds expected second week of December 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.6 AUD | -.--% |
|
-5.04% | -.--% |
15/05 | Medlab Clinical Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
24/04 | Medlab Clinical Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 10.02M | |
+16.49% | 122B | |
+21.73% | 115B | |
+23.26% | 26.64B | |
-21.81% | 19.91B | |
-16.80% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- MDC Stock
- News Medlab Clinical Limited
- Medlab Clinical Limited Invoices First Royalty Cheque to PharmaCare